Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
To talk about those stats, more specificity is required. Mortality rate is the relationship between known cases and the amount of death.
Another way to consider the figures: We have the most death, but our amount of death by 1 million population is lower than most countries.
So, low death compared to our population but not the best death rate as compared to known ceases. But this is probably a better number if you consider all the cases that were never diagnosed.
Besides that: Here we go, back to, “$25-$30 next week.”
That isn’t happening guys. This will still take longer than you think. You know how many times I’ve seen many posters saying “$60 by end of the week”, or, “$30 tomorrow !”
Hold your horses. It may come. But listen to Black Ops. Look down the road. You’re not going to be a millionaire on Monday morning. And that’s okay...
Unfortunately it feels this way. Still have lots of hope for the drug, but this is not where anyone expected to be given the PR and expectations set this summer and recent weeks. And everyone knows it, even if we won’t admit it publicly. Doesn’t seem like we’re going to get Nasdaq and besides that the only thing sufficient to move SP is some sort of approval or high level endorsement, which are not forthcoming. Looks like we’re waiting for HIV.... which could still be great. But nothing’s happening here for a while. Might as well just hold your shares and take a break, learn an instrument or a new language and come back when there’s something real on the horizon.
I expected better things too...
Maybe that’s right and it’s just been unclear. Sometimes the language is ambiguous and hard to follow. I believe I saw analysis of 168 AFTER 195 have been enrolled....
oh well.
Success won’t come until we have real hard data on the S/C anyway so we’ll be waiting until then, however long that takes.
This is right.
NP said they would do analysis on 168 patients ONCE they reached full enrollment of 195. Not sure why that was the protocol. Must be a reason to set it up that way, I don’t know. But that’s what the plan was.
I’m not sure why you wouldn’t just do interim analysis for all 195 once they were all enrolled .. and complete the timeline. But I don’t know everything about these things so that doesn’t mean anything.
Forgive me guys... is there a White House presser tonight? If so what time? Topic of discussion? Who’s speaking? Covid task force, or will prez be there as well?
Indeed. Thanks very much. Too many news subscriptions as it is.. can’t subscribe to the whole world of journalism. Wouldn’t make my car payments...
Ok. Is it just behind a paywall? It seemed to me to have been taken down.. as it says “no longer active”. If you’re subscribed to Forbes is it still accessible?
Outstanding. Thanks for getting back so quickly. Sorry I’m just coming to all of this now. Do we know just how long the article was live before it was censored? Any compelling rationales for why it would be censored? Real discernible reasons, not just conspiracy... (not ruling that out, but starting without that assumption usually best).
Does anyone have access to this article from before they blurred it out? Can we find it in the “way back machine” by any chance?
Who knows how to do that? Or someone who read the Article and can sum up its major points. I.e. endorsements, sources etc.,
This is correct. The spell has temporarily worn off. We had major pile on this spring/summer. This was part of the larger Covid play. At the time, we seemed to people brand new to the company to have something truly novel that had the potential, if not to totally destroy Covid, at least become part of a combo therapy regime, which would take our drug around the world. That would have been extraordinarily big news. People hung around, bought more, listened to CCs, bought some more, saw filings, bought more.... then the short attack stole a lot of the balls everyone had gotten up to invest in an OTC in the first place. That event cannot be overestimated in its destructive effect on this stock I believe. But we didn’t bounce back from it.. and we could’ve. At least we could be sitting at $7 right now. But company failed at getting those horrified and jaded investors back in the game. Some held. Many sold. A few bought more. But as the last 6 weeks have gone by, the company hasn’t assuaged concerns about the future sufficiently. Only exasperated them, apparently. The market doesn’t lie. I’m not saying that SP won’t be back. But it’s not coming back without at least 1, more likely 2 out of 3 things. We know what the 3 potential good news stories/developments are. Without them. We sit and spin. Trading, unlike Cary Grant, South by Southwest. The novelty of this equity has worn off. And ONLY hard undeniable proof will bring it back. FDA WILL make us do phase 3. They’re obviously satisfied currently with SOC and they’re not about to go out on a limb based on the decent data from our phase 2. HIV is what we’re waiting for now. Unless our phase 3 is outstanding and we meet/exceed primary endpoint.
GLTALongs
I think everything in this message is exactly right. However, I do believe we will see bounce after uplist. Not a slide.
This is %100 on point. Leaves very little to elaborate on. We’re treading water now, trading sideways under $5 while we should be sitting above $7.
Just because our big picture is (fill in the blank), doesn’t mean we have to spend the past and coming few months where we are. Companies are supposed to provide value for shareholders and a part of that is the packaging the gift is wrapped in.
There have been maybe 4 blown opportunities for $1 bounces, which probably could’ve sustained themselves, had news been organized in content and in timing.
Buyers will be back but not until something major is afoot. It’s no longer sufficient to seduce retail investors with a little bit of this and that. They’re not buying it. So, hopefully we make it to the show.
The only things that will precipitate %30 days again are:
1. Nasdaq-OFFICIAL
2.Approval
Maybe 3. The commencement of a Phase 3 related to the trial we just finished.
4. UnBELIEVEABLE numbers coming out of the S/C.
Anything short of these 4 potentialities will not get us back to where we belong. So, buy on the dips I guess. But don’t rush it. There’s a fair bit of time before any of those goals materialize.
Ahh thank you very much. I missed that piece. So Mexico wanted to trial Lero as a part of some kind of combination therapy...
thank you for clearing that up.
That is a nice tid-bit to be sure. BP’s confidence is a huge part of what’s keeping me here, no doubt.
Yes,yes and yes. See my last post. The risk is too high for the cohort who took us to $10. They’re waiting for a big sign now. Not an ambiguous paper that’s really only being seen by some medical professionals and a small handful of investors who already own and believe in the drug. The net isn’t wide enough and the holes are too damn big.
I unfortunately think this is right. This is where we are. If we can’t get to approval we’re going nowhere until they complete the end all HIV trial That brings Lero to market for that disease. I don’t think anyone is arguing against BP. People here are talking about the stock and its trading value, valuation and market read of the situation. It’s obvious that the current data accessible to the public is insufficient to precipitate any major retail buying of the equity. Most and I mean most of the people who watch and listen and read the CCs and PRs etc are existing investors. We’re not winning anyone over right now. We were earlier this summer but that new cohort of investors has mostly bailed now or are holding much smaller positions. That’s because while they were new to the stock they paid attention. And while they were paying close attention the company promised things they couldn’t deliver. Gave radically inaccurate timelines etc.. I think people would have sat it out a little longer had the expectations been managed better, but not a lot of people want to white knuckle this thing when deadlines are missed and we’re just not breaking through. OTC remember? That’s a hell of a mountain to climb that’s made of pure risk. It’s not a good time for many of us Americans to be buried in a mountain of risk. We’re out of work.. people would rather put their money to work where it’s working. If you were in PENN even one month ago but really 3 months ago you’re making tons of $$. There are so many stocks performing incredibly right now. It’s truly amazing how much $$ there is floating around if you can wait a month of this recovery. Every day new records are being set. Incredible. But CYDY isn’t proving enough currently and people want their money to work for them. That’s all it is. Shorts too, sure. No doubt. But that harkens back to the risk factor that most people aren’t up for at this moment. At this point it will take a huge step forward to blow us upward. Maybe it won’t take actual approval but something approximating that major of a development. Anyway... if the stock trades at $4.50 one morning and “FDA POSTS APPROVAL FOR CYDY’s LERONLIMAB” hits the page, people still have time to buy. Because that is major. So, they’re waiting it out and will get back in when it’s actually on the rise. Not while it’s trading sideways treading water.
Sorry. That’s where we are. End of story. I believe in Dr BP. I think he’s brilliant. But one smart doctor doesn’t move the market like we might want it to. Period. This isn’t just about the drug for most investors. It’s About making $$$$. And it seems many posters here are forgetting that that is the motivation for most folks.
GLTALongs.
Fingers crossed man.
Someone ask about Mexico status in the call tomorrow if we get Q&A. Haven’t heard peep about it in a month. Last was expressing disappointment that Mexico hadn’t gotten their s*#t together after CYDY sent over their protocol.
But still. Because it was a big news story at the time and it seemed like that was not only going to be a thing, but it was gonna to be fairly quick and easy, we are entitled to the plan, status, or if it was scrapped then so be it.
Now we have potential application in U.K. What if that just turns out to be another Mexico? I’d like some closure.
Right on brother, right on. Bodes well.
Pretty on point. Severe trial results I think will nearly double the positive results of this one. If we are forced to do a phase 3 based on these results then it’ll be the S/C trial that wins the game.
I’m just worried that we might see approval but we’re not listed as a new SOC. Those are the things I think the institutions will actually keep out of our reach. I’m not into the conspiracies as much regarding BP. Shady sometimes. Sure. But a grand sort of conspiracy against us? No. We will get approval if results are sufficient. However, when it comes to being promoted as the new SOC or a major endorsement or advocation by the top brass, I’m not holding my breath. We will be passed over for that sort of thing given our position as a small startup etc etc.
Thanks cowtown.
I’ve perused this before also, but I wonder if there’s sufficient public data on the company to have any degree of certainty of our success on this front.
Yes, this is somewhat surprising to me too.
I would be just thrilled.
Did Redsvr get theirs after a Phase 2 only ?
This is exactly what I predicted. Some of the PhDs did as well if I remember correctly. BP said, “even more so,” when discussing the effects of the drug on MM patients, expecting the sicker to experience more benefit. The other trial will be the one. Also Phase 3 so that’s our last stop before approval.
FDA is gonna ask us for a phase 3 based on results just disseminated.
Yes. We experience very bizarre action on this particular security. A confluence of factors I think. Sure, shorting is a big part of it. But it’s all the things...
uplist is absolutely crucial to our taking the next step. If we fail on that we WILL not see the growth we want out of our positive results. Period. Half of what our SP would be if trading in the majors. Can’t even stay above $5 for any significant period.
Still waiting for anyone who can outline the prerequisites for NASDAQ next to the publicly available data on the company that proves we are qualified for the market. Not sure if that’s been passed around but I have not seen it yet. Some pieces here and there. But I’m not totally convinced until we read that post that we will make the NASDAQ. Anyway, news on that front before the month I’m sure...
Fingers crossed
I supremely doubt that guys. That’s not to be a naysayer but really, Trump just says simple words because they’re the most relatable to the wisest possible audience. He does it on al topics, all the time. Yes, okay, maybe there’s some specificity there. But do I think he actually knows the name of our drug and he’s keeping it locked up inside that addled old brain? No, I’d wager against it.
Yes. I’m willing to wait on that provided with certainty that we qualify for the move up to major market. However I don’t expect for this to be the sequence of events. News on M2M presumably will release this week and we will find out about uplist in September. Will definitely be fascinating these next two months.
Still looking for a list of how we meet the prerequisites for uplist. If enough of those data are public and accessible.
That really will be the game changer. Truly. That gives us a much more accurate picture, valuation, as determined by the investment set.
It also seems to me that the MM are in the driver’s seat to some degree. It’s extremely frustrating as a Long on this stock. A myriad of bizarre things going on around us.
Uplisting before approval would also be optimal. Even with approval, when still on OTC, we won’t get the true picture of SP as determined by public and institutions. Maybe we triple the SP upon approval on OTC but we would quintuple it on NASDAQ. I wish that would come before results.
I’m still looking for someone to prove to me, insomuch as that’s possible with public info and DD that we will unquestionably qualify and be granted access to the big show.
If anyone has a list of the prerequisites for NASDAQ with our corresponding data side by side I would love to see it.
I don’t think that’s been borne out on a post in total. But maybe one of you gentlemen has that intel.
Thanks.
GLTALongs
Fingers crossed
I would be also be very curious to know this tid-bit of information. Lemme know if you find out.
Been away a few days.
How do we know results are coming Tuesday after close ?
Is that really a thing guys?
Prediction or fact found?
Guys. Updated ideas on release of M2M data? What kind of timeline do we think we’re waiting on at this point? Next week? What’s going on. Typically these things take 4-6 weeks. Nader said a couple of days but, “be patient.” Is it even reasonable to think they’ll have it done before the 4-6 week typical ? Or is it just going to take how long it usually does and that means another 2-3 weeks? This is why the stock is in the toilets. I’ve been saying, just because you believe the stock will be at $20 end of year or $500 in 5 years does not necessitate us sitting under $4.50 at this moment. Does not instill much faith. I’m feeling a little pessimistic about the Uplisting too. If we are denied and fail on that point we will fall another $1. I’m not positive we’re going to make it on this application. Nobody seems to have detailed all the prerequisites and our status in meeting them to my satisfaction.
This is correct. Maybe even worse than that.
And the reply to this message is correct as well. Frustrated by the slow enrollment in S/C. Not exactly sure what is holding it up and how much of those prerequisites are in their hands but, damn.
The longer it takes the more vaccine and therapeutic news is released and our bomb upon approval has less explosive power. Mexico trial is where..?
I know NP blamed it on their health institute recently but is it really their fault? Do we know, how do we know?
It would presumably be easier to get approval outside of the US because I’m not even convinced that we’ll get approval on the basis of “unmet medical need.”
There are some drugs meeting the need. Not perfectly of course. Inefficiently in places sure. But it’s not unmet. We’re not in a vacuum on this thing. Frustrating to be sitting under $5 again when I think we should be up at $7. I know many have waited since 30cents but that was a different time. Not as much going for us then. And those years spent at 30cents tied up capital that could’ve been used to make money elsewhere in the mean time. I want them to stop shooting themselves in the foot with these timelines. If they were more honest and forthcoming and REALISTIC the WSJ wouldn’t have been able to target us like that. Oh well
Fingers crossed.
This I understand. The process of it and when and why they might suspend the trial for various reasons. Thank you, very much. I am wondering where and how we know exactly when the board is meeting... I can’t recall an update on that with all the various CCs and interviews to keep up on. Do we have that Monday meeting as a hard date? Or is that likely still fluid? Also, am I correct that the only way we will learn anything about this meeting is an announcement of stopping or it’s continuance? We don’t expect to have some sort of release with any specific dats points in either scenario, do we?
Thanks.
GLTALongs
Hey guys.. so what’s the current expectation for the safety committee deal on S/C trial? That got muddled this last week for me and can’t remember if there was a real timeline of expectation on that issue? Thanks very much
BP on Yo was a great little interview. He’s a pretty solid communicator. That’s why the Ted Talk was such a success. And I don’t even think he’s trying. He’s not focused on it at all. Being effective in his speech that is. If he applied effort to it he could be outstanding. Always impressed with him and his stance and read on Lero gives me a lot of hope and allows me to remain sanguine on this whole deal.
This proactive video was one of the cringiest things yet. Is it true that because we’re an OTC stock we are “obligated to refute untrue statements?”
Everyone that has a blog must be corrected..? Eeesh. Can you imagine a big time CEO, I say again, CEO! From, pick your favorite major corporation, responding to some garbage blogger from a website nobody has ever heard of outside a tiny investment community ? It’s unthinkable.
Someone recently posted the only conditions which would call for a PR or CC or appearance on some program.. and this poster is correct. Only progress counts. Not appearing in order to try to assuage shareholders about some pr*#k who makes his money talking trash and shorting stocks. This is not how major players behave. And we are ostensibly a major player. At least aspiring to be one. This makes us look silly and incapable of handling our own stuff. Nobody sees these proactive videos except investors anyway so this is directed at us. Who already believe in the drug. I don’t need NP to tell me AF is full of garbage. This plays right into the hands of AF and the shorts. They are getting to him. Or it at least it reads that way. And that isn’t a good book. What a waste. If anything, if NP felt compelled to do this appearance he should’ve just reiterated the results he spoke of yesterday. In hopes of making it more easily intelligible and more widely known. But now we’ve wasted 10 more “media” minutes on useless trash that doesn’t help anyone. I don’t feel anymore sanguine about this investment because of this video. And all the appearances should have that as their object. That’s the point of PR. I’m not having fun saying these sorts of things. I want to celebrate hard work and positive results. But now our CC yesterday is overshadowed by being followed up IMMEDIATELY, the next day, with petty nonsense. Man.
I know some have started saying “armchair CEOs.” And well, that’s fair enough. I don’t say I could do it better myself generally. But I can identify mistakes when they appear. Just as you can when watching a basketball game or whatever. Failure is evident upon inspection. And with so much to look forward to, near and long term, we are spending an awful lot of our time holding ourselves back. Just because we expect $20 SP by the end of the year, or whatever your best estimate is, doesn’t mean we are doomed to spend August under $6. And that’s the point.
GLTALongs.
Fingers crossed.
3x has it right. Black Ops has it right. Smiley has it right. And I don’t disagree with Scooter as much as many of you seem to have recently taken up. I think he’s got it right too.
And because of all these true utterances, we don’t need our busy and honest hard working CEO rebutting every piece of nonsense propaganda written by this dumpster fire starter. Opportunity costs is a concern. Opportunity costs are of major importance when trying to get off the ground.
Wait. are you guys of the opinion that DR. NP is saying “10 days until results in detail disseminated” when he secretly knows it’s coming in 5 in order to short trap the shorts?
Where are you getting this from?
And if you know that that’s the plan then the shorts can know it too? No?
This proactive video was one of the cringiest things yet. Is it true that because we’re an OTC stock we are “obligated to refute untrue statements?”
Everyone that has a blog must be corrected..? Eeesh. Can you imagine a big time CEO, I say again, CEO! From, pick your favorite major corporation, responding to some garbage blogger from a website nobody has ever heard of outside a tiny investment community ? It’s unthinkable.
Someone recently posted the only conditions which would call for a PR or CC or appearance on some program.. and this poster is correct. Only progress counts. Not appearing in order to try to assuage shareholders about some pr*#k who makes his money talking trash and shorting stocks. This is not how major players behave. And we are ostensibly a major player. At least aspiring to be one. This makes us look silly and incapable of handling our own stuff. Nobody sees these proactive videos except investors anyway so this is directed at us. Who already believe in the drug. I don’t need NP to tell me AF is full of garbage. This plays right into the hands of AF and the shorts. They are getting to him. Or it at least it reads that way. And that isn’t a good book. What a waste. If anything, if NP felt compelled to do this appearance he should’ve just reiterated the results he spoke of yesterday. In hopes of making it more easily intelligible and more widely known. But now we’ve wasted 10 more “media” minutes on useless trash that doesn’t help anyone. I don’t feel anymore sanguine about this investment because of this video. And all the appearances should have that as their object. That’s the point of PR. I’m not having fun saying these sorts of things. I want to celebrate hard work and positive results. But now our CC yesterday is overshadowed by being followed up IMMEDIATELY, the next day, with petty nonsense. Man.
I know some have started saying “armchair CEOs.” And well, that’s fair enough. I don’t say I could do it better myself generally. But I can identify mistakes when they appear. Just as you can when watching a basketball game or whatever. Failure is evident upon inspection. And with so much to look forward to, near and long term, we are spending an awful lot of our time holding ourselves back. Just because we expect $20 SP by the end of the year, or whatever your best estimate is, doesn’t mean we are doomed to spend August under $6. And that’s the point.
GLTALongs.
Fingers crossed.
Heard that. I’m not selling either, big guy.
I want to see it on paper. It’s nice to be able to review it and make references and not try to listen on a webcast and remember everything. I expect great top line breakdown to be sure. Always have.
GLTALongs
No. Absolutely not. This data is not ready yet. Absorb that fact. It will help you temper your expectations and adjust your timelines. These are the things that “shake out weaker hands.” And it’s not their fault. When promises made become promises broken investors loose faith and the SELL. It’s not just shorts comrades. They play a big part. (Thanks to those who post the data most every day). But our self immolation is destroying share holder confidence as well. If you don’t see or believe that when I say it you’ve lost touch.
We never should have had this CC yesterday. Can anyone point to the incredible data we didn’t have yesterday morning, but was so important that we had to have it for today? What prey tell is the golden nugget data point from yesterday? The game changer...
No. The data isn’t ready yet. And we should be waiting quietly until it’s prepared. I’ve said it before. If we have what we think we have and most of the anecdotal data supports it, and the safety data supports it, we should be slowly but steadily climbing in value as more people discover the investment opportunity. Instead we get half a** CC that are totally underwhelming, bait and switch of an investment deal when what really will drive this stock is efficacy, and more timelines blown up. Self. Inflicted. Wounds. This is what people are getting tired of. The horse seems to be too much of a thoroughbred for the jockey to keep control. We need PR expertise and a team of people to help bring this drug to market. Dr. NP said the EXACT same thing. “We don’t need to discover a new molecule, we don’t need scientists, we have the molecule. We need people with experience in drug development.” He was right on that time. He doesn’t need to jump ship. I think we all can appreciate his value up until this point, but step to the side? Yes. Poor decision making is keeping us under $5. Poor expectations management is keeping us under $6.
I guess the shorts get another day to cover under $5 huh? Guess I better run and cover now Andy? My last chance (again) right?
I’ve never been short this stock, not one share, ever. I still believe, no matter how hard NP is trying to make me feel otherwise.
I hope the uplist is successful and we can move beyond this Mickey Mouse garbage trading into where we belong.